FIELD: medicinal chemistry.
SUBSTANCE: use of decanoic acid, or a pharmaceutically acceptable salt, amide or ester thereof, for the manufacture of a drug and the treatment of epilepsy.
EFFECT: provision of strong antiepileptic drugs with reduced side effects.
1 cl, 9 dwg, 3 tbl
Title | Year | Author | Number |
---|---|---|---|
THERAPEUTIC APPLICATION OF COMPOUNDS | 2011 |
|
RU2640596C2 |
ESTERS OF BETA-HYDROXYBUTYRATE AND BUTANEDIOL FORMED BY MEDIUM-CHAIN FATTY ACIDS AND COMPOSITIONS AND METHODS BASED ON THEM | 2017 |
|
RU2761829C2 |
USE OF DERIVATIVES OF 2-HYDROXY-5-PHENYLAZOBENZOIC ACID AS CHEMOPROPHYLACTIC AND CHEMOTHERAPEUTIC AGENTS INCOLON CANCER | 1995 |
|
RU2161487C2 |
COMBINATION CONTAINING DECANOIC ACID FOR TREATMENT OF EPILEPSY | 2018 |
|
RU2779202C2 |
COMPOSITION FOR USE IN THE TREATMENT OF EPILEPSY | 2018 |
|
RU2793246C2 |
METHODS AND COMPOSITIONS WITH APPLICATION OF IMMUNOMODELLING COMPOUNDS IN COMBINED TREATMENT | 2007 |
|
RU2426542C2 |
APPLICATION OF 2-HYDROXYDERIVATIVES OF POLYUNSATURATED FATTY ACIDS AS MEDICATIONS | 2010 |
|
RU2513995C2 |
COMPOUNDS OF BENZOXAZEPINOXAZOLIDINONES AND METHODS OF USING | 2016 |
|
RU2730529C2 |
INHIBITORY SOLUTION AND METHOD OF SUPPRESSION OF PAIN, INFLAMMATION OR SPASM | 1995 |
|
RU2180852C2 |
ALPHA-DERIVATIVES OF CIS-MONOUNSATURATED FATTY ACIDS APPLICABLE AS THERAPEUTIC AGENT | 2009 |
|
RU2531353C2 |
Authors
Dates
2023-11-02—Published
2011-11-24—Filed